Management of prolonged cytopenia following CAR T-cell therapy Correspondence

  

Authors:	Corona, M.; Shouval, R.; Alarcón, A.; Flynn, J.; Devlin, S.; Batlevi, C.; Mantha, S.; Palomba, M. L.; Scordo, M.; Shah, G.; Sauter, C.; Perales, M. Á; Dahi, P. B.
Title:	Management of prolonged cytopenia following CAR T-cell therapy
Keywords:	clinical article; drug approval; outcome assessment; letter; mantle cell lymphoma; neutrophil count; anemia; thrombocytopenia; hemoglobin; food and drug administration; retrospective study; disease severity; disease duration; romiplostim; cytopenia; adoptive immunotherapy; immunotherapy, adoptive; platelet count; adverse event; diffuse large b cell lymphoma; humans; human; chimeric antigen receptor t-cell immunotherapy; lisocabtagene maraleucel
Journal Title:	Bone Marrow Transplantation
Volume:	57
Issue:	12
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Date Published:	2022-12-01
Start Page:	1839
End Page:	1841
Language:	English
DOI:	10.1038/s41409-022-01771-x
PUBMED:	36131002
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138433821&doi=10.1038%2fs41409-022-01771-x&partnerID=40&md5=ef62f7f0184bee4b23f71ce89a901b57
Notes:	Letter -- Export Date: 3 January 2023 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/201898